CASI Pharmaceuticals Inc. (NASDAQ: CASI)
$2.6700
+0.0900 ( +3.49% ) 26.2K
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
Market Data
Open
$2.6700
Previous close
$2.5800
Volume
26.2K
Market cap
$39.97M
Day range
$2.5800 - $2.7850
52 week range
$2.0500 - $8.1900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 1 | Jan 21, 2025 |
| effect | Other | 1 | Dec 31, 2024 |
| 6-k | Form 6-K | 1 | Dec 26, 2024 |
| f-3/a | Other | 1 | Dec 23, 2024 |
| f-3 | Other | 14 | Dec 20, 2024 |
| 6-k | Form 6-K | 1 | Dec 16, 2024 |
| 6-k | Form 6-K | 3 | Nov 15, 2024 |
| sc | Insider transactions | 1 | Oct 29, 2024 |
| 6-k | Form 6-K | 1 | Sep 12, 2024 |
| effect | Other | 1 | Sep 03, 2024 |